Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan Medical Device Investing
Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026 Medical Device Investing
Viemed Healthcare Announces First Quarter 2026 Earnings Conference Call Details Life Science Investing
During an Altaviva Implant, the Patient Talked About Lunch. That Was the Point Medical Device Investing
Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab Platform Pharmaceutical Investing
Ocumetics Reports Improvement in Six Month First-in-Human Results Meaningful Improvements in Patient Quality of Life Technology Investing
Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions Medical Device Investing
